Clinical Trial Update: Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating thalidomide with chemotherapy and as maintenance for HER2-negative advanced gastric cancer, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Gastric Cancer Metastatic to Liver | Phase 1, Phase 2 | Status: UNKNOWN